- Home
- SGBX vs PRFX Comparison
SGBX vs PRFX Comparison
Compare SGBX & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- PRFX
- Stock Information
- Founded
- SGBX 2007
- PRFX 2007
- Country
- SGBX United States
- PRFX Israel
- Employees
- SGBX N/A
- PRFX N/A
- Industry
- SGBX RETAIL: Building Materials
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- PRFX Health Care
- Exchange
- SGBX Nasdaq
- PRFX Nasdaq
- Market Cap
- SGBX 2.7M
- PRFX 2.9M
- IPO Year
- SGBX 2017
- PRFX 2020
- Fundamental
- Price
- SGBX $0.66
- PRFX $1.41
- Analyst Decision
- SGBX
- PRFX Hold
- Analyst Count
- SGBX 0
- PRFX 1
- Target Price
- SGBX N/A
- PRFX N/A
- AVG Volume (30 Days)
- SGBX 1.1M
- PRFX 180.3K
- Earning Date
- SGBX 06-13-2025
- PRFX 08-14-2025
- Dividend Yield
- SGBX N/A
- PRFX N/A
- EPS Growth
- SGBX N/A
- PRFX N/A
- EPS
- SGBX N/A
- PRFX N/A
- Revenue
- SGBX $4,574,857.00
- PRFX N/A
- Revenue This Year
- SGBX $1,628.82
- PRFX N/A
- Revenue Next Year
- SGBX N/A
- PRFX N/A
- P/E Ratio
- SGBX N/A
- PRFX N/A
- Revenue Growth
- SGBX N/A
- PRFX N/A
- 52 Week Low
- SGBX $0.30
- PRFX $1.25
- 52 Week High
- SGBX $2.95
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- SGBX 46.23
- PRFX 33.30
- Support Level
- SGBX $0.60
- PRFX $1.37
- Resistance Level
- SGBX $0.97
- PRFX $1.50
- Average True Range (ATR)
- SGBX 0.11
- PRFX 0.10
- MACD
- SGBX -0.03
- PRFX -0.02
- Stochastic Oscillator
- SGBX 22.73
- PRFX 19.74
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.